Financial reports
10-Q
2024 Q1
Quarterly report
20 Feb 24
10-K/A
2023 FY
Annual report (amended)
15 Feb 24
NT 10-Q
Notice of late quarterly filing
15 Feb 24
10-K
2023 FY
Annual report
5 Jan 24
NT 10-K
Notice of late annual filing
29 Dec 23
10-Q
2023 Q3
Quarterly report
21 Aug 23
NT 10-Q
Notice of late quarterly filing
15 Aug 23
10-Q
2023 Q2
Quarterly report
15 May 23
10-Q
2022 Q1
Quarterly report
21 Feb 23
NT 10-Q
Notice of late quarterly filing
15 Feb 23
Current reports
8-K
Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
6 Mar 24
8-K
Other Events
27 Nov 23
8-K
Theralink Technologies Appoints Faith Zaslavsky as Chief Executive Officer
29 Jun 23
8-K
Theralink® Signs Definitive Merger Agreement to be Acquired by
26 May 23
8-K
Departure of Directors or Certain Officers
11 May 23
8-K
Entry into a Material Definitive Agreement
1 Feb 23
8-K
Theralink® Technologies Appoints Seasoned Commercial Leader, Faith Zaslavsky, as President & Chief
8 Dec 22
8-K
Theralink® Technologies Announces Closing of Private Placement and Conversion of Existing Convertible Notes and Convertible Preferred Shares
1 Dec 22
8-K
Entry into a Material Definitive Agreement
16 Sep 22
8-K/A
Amendments to Articles of Incorporation or Bylaws
11 Jul 22
Registration and prospectus
425
Business combination disclosure
26 May 23
D
$3.40 mm in debt / options, 12 investors
14 Dec 22
D
$4M in equity, sold $400K, 4 investors
12 Feb 21
D
$184.95K in debt / securities to be acquired, sold $184.95K, 36 investors
29 May 19
D
$1.23M in debt / securities to be acquired, sold $1.23M, 4 investors
9 Oct 18
424B3
Prospectus supplement
16 May 17
POS AM
Prospectus update (post-effective amendment)
12 May 17
POS AM
Prospectus update (post-effective amendment)
1 May 17
424B3
Prospectus supplement
23 Sep 16
POS AM
Prospectus update (post-effective amendment)
15 Sep 16
Proxies
DEF 14C
Information statement
2 Jun 22
PRE 14C
Preliminary information
20 May 22
DEFM14C
Information related to merger
31 Aug 20
PREM14C
Preliminary information related to merger
19 Aug 20
SC 14F1
Statement regarding change in majority of directors
8 Jun 20
DEF 14C
Information statement
13 May 19
PRE 14C
Preliminary information
30 Apr 19
DEF 14C
Information statement
6 Mar 19
PRE 14C
Preliminary information
22 Feb 19
DEF 14C
Information statement
6 Aug 15
Other
UPLOAD
Letter from SEC
24 Jul 20
CORRESP
Correspondence with SEC
22 Jul 20
UPLOAD
Letter from SEC
20 Jul 20
EFFECT
Notice of effectiveness
15 May 17
CORRESP
Correspondence with SEC
12 May 17
UPLOAD
Letter from SEC
11 May 17
EFFECT
Notice of effectiveness
20 Sep 16
CORRESP
Correspondence with SEC
15 Sep 16
UPLOAD
Letter from SEC
6 Sep 16
EFFECT
Notice of effectiveness
3 Dec 15
Ownership